Are you 18-35 years old? Do you have a Nexplanon® implant (also called an etonogestrel implant)? You may be able to participate in a research study to find out if Nexplanon is safe and effective for use beyond three years. Eligible participants have a Nexplanon implant that was inserted 34–36 months ago (almost three years ago). Compensation is provided.
Nexplanon® (also called an etonogestrel implant) is a long-acting, reversible, hormonal birth control used by women to prevent pregnancy. Nexplanon is approved for use for up to three years, but some evidence suggests that Nexplanon may prevent pregnancy for a longer period of time. The purpose of this study is to find out if Nexplanon is safe and effective for use beyond three years.
COULD THIS STUDY BE RIGHT FOR YOU?
- Ages 18-35
- Assigned female at birth
- Have a Nexplanon® (etonogestrel) implant that was inserted 34–36 months ago (almost three years ago)
- Are willing to continue to use the etonogestrel implant for an additional 24 months and do not intend to use any other form of contraception (for example, condoms)
- Are able to get pregnant
WHAT PARTICIPANTS CAN EXPECT
This study lasts for about 27 months (a little over two years) and includes 11 in-person visits. Visits will include urine pregnancy tests, collection of blood, and pelvic exams. Participation will also involve you recording your daily experience with any vaginal bleeding or spotting and answering questions about your sexual activity each month.
IRB: SSU00140373- Merck Sharp & Dohme Corp. - MK-8415-060, A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger (Pro00045987)
MEET THE RESEARCHER
Suji Uhm, MD, MPH is an Assistant Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences. She completed a fellowship in family planning at University of California, Davis and is an experienced clinician in gynecologic and contraceptive care.